These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium. Taetle R; Caviles A; Koziol J Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965 [TBL] [Abstract][Full Text] [Related]
3. [Colony-stimulating activity of bone marrow preparations in patients with different pathology of the blood]. Zubarovskaia LS; Afanas'ev BV; Smirnova GA; Lukasheva TN; Patterson D Ter Arkh; 1985; 57(7):22-7. PubMed ID: 3876612 [TBL] [Abstract][Full Text] [Related]
4. Comparison of colony-stimulating activities for evaluating in vitro granulomonopoiesis in normal subjects and in patients with myeloid leukemias. López-Karpovitch X; Padrós-Semorile MR; Hurtado-Monroy R; Cárdenas MR; Niesvizky N; Martínez-Sánchez L; Rojas R Rev Invest Clin; 1985; 37(4):323-7. PubMed ID: 3879370 [No Abstract] [Full Text] [Related]
5. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Betticher DC; Huxol H; Müller R; Speck B; Nissen C Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233 [TBL] [Abstract][Full Text] [Related]
6. An in vitro study of basophil production in chronic myeloproliferative disorders. Piacibello W; Camussi G; Aglietta M Exp Hematol; 1984 Nov; 12(10):759-62. PubMed ID: 6334609 [TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias. Blazsek I; Farabos C; Quittet P; Labat ML; Bringuier AF; Triana BK; Machover D; Reynes M; Misset JL Cancer Detect Prev; 1996; 20(1):31-42. PubMed ID: 8907201 [TBL] [Abstract][Full Text] [Related]
10. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro. Korycka A; Robak T Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305 [TBL] [Abstract][Full Text] [Related]
11. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow cultures in acute leukemia of childhood. Ragab AH; Kennedy MS; Findley HW; Lui VK Am J Pediatr Hematol Oncol; 1981; 3(4):419-24. PubMed ID: 7036782 [TBL] [Abstract][Full Text] [Related]
13. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture. Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
15. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis. Vincent PC; Rutzen-Loesevitz L; Tibken B; Heinze B; Hofer EP; Fliedner TM Stem Cells; 1999; 17(1):9-17. PubMed ID: 10215403 [TBL] [Abstract][Full Text] [Related]
16. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression. Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986 [TBL] [Abstract][Full Text] [Related]
17. The levels of granulocyte colony-stimulating factor in the plasma of the bone marrow aspirate in various hematological disorders. Shinohara K; Oeda E; Nomiyama J; Inoue H; Kamei S; Tajiri M; Ichikawa T; Kuwaki T; Tachibana K Stem Cells; 1995 Jul; 13(4):421-7. PubMed ID: 7549901 [TBL] [Abstract][Full Text] [Related]
18. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
19. [Role of colony-stimulating factor in granulopoiesis disorders in myeloid leukemias]. Hellmann A Acta Haematol Pol; 1979; 10(3):211-5. PubMed ID: 315691 [No Abstract] [Full Text] [Related]
20. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation. Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]